Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the relationship between the side effects of
cyclophosphamide in the treatment of systemic lupus erythematosus (SLE) in Han Chinese and
the genetic polymorphisms of drug metabolizing enzymes and pharmacokinetics of
cyclophosphamide.